The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Recent discovery and development of inhibitors targeting coronaviruses
Open accessAbstract
Human coronaviruses (CoVs) are enveloped viruses with a positive-sense single-stranded RNA genome. Currently, six human CoVs have been reported including human coronavirus 229E (HCoV-229E), OC43 (HCoV-OC43), NL63 (HCoV-NL63), HKU1 (HCoV-HKU1), severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and MiddleEast respiratory syndrome (MERS) coronavirus (MERS-CoV). They cause moderate to severe respiratory and intestinal infections in humans. In this review, we focus on recent advances in the research and development of small-molecule anti-human coronavirus therapies targeting different stages of the CoV life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.03.003 · Cited by 2,948
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., Ahuja, A., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,628
The Molecular Biology of Coronaviruses
Masters, P. S. (2006) · Advances in Virus Research · doi:10.1016/s0065-3527(06)66005-3 · Cited by 1,761
Woo, P. C. Y., Lau, S. K. P., Lam, C. S. F., Lau, C. C. Y., Tsang, A. K. L., Lau, J. H. N., Bai, R., Teng, J. L. L., Tsang, C. C. C., Wang, M., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06540-11 · Cited by 1,677
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
Chu, C. M. (2004) · Thorax · doi:10.1136/thorax.2003.012658 · Cited by 1,645
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
Booth, C. M. (2003) · JAMA · doi:10.1001/jama.289.21.joc30885 · Cited by 1,406
Brass, A. L., Huang, I.-C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.017 · Cited by 1,269
Effects of chloroquine on viral infections: an old drug against today's diseases
Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., & Cauda, R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00806-5 · Cited by 1,268
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection
Cheng, V. C. C., Lau, S. K. P., Woo, P. C. Y., & Yuen, K. Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-07 · Cited by 1,192
Mair-Jenkins, J., Saavedra-Campos, M., Baillie, J. K., Cleary, P., Khaw, F.-M., Lim, W. S., Makki, S., Rooney, K. D., Convalescent Plasma Study Group, Nguyen-Van-Tam, J. S., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu396 · Cited by 983
Human aminopeptidase N is a receptor for human coronavirus 229E
Yeager, C. L., Ashmun, R. A., Williams, R. K., Cardellichio, C. B., Shapiro, L. H., Look, A. T., & Holmes, K. V. (1992) · Nature · doi:10.1038/357420a0 · Cited by 941
van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T. M., Raj, V. S., Zaki, A. M., Osterhaus, A. D. M. E., Haagmans, B. L., Gorbalenya, A. E., Snijder, E. J., et al. (2012) · mBio · doi:10.1128/mbio.00473-12 · Cited by 914
A New Virus Isolated from the Human Respiratory Tract.
Hamre, D., & Procknow, J. J. (1966) · Experimental Biology and Medicine · doi:10.3181/00379727-121-30734 · Cited by 884
Chan, J. F. W., Lau, S. K. P., To, K. K. W., Cheng, V. C. C., Woo, P. C. Y., & Yuen, K.-Y. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-14 · Cited by 881
Báez-Santos, Y. M., St. John, S. E., & Mesecar, A. D. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2014.12.015 · Cited by 854
Schaeffer, M. (1971) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1971.20.3.tm0200030508a · Cited by 762
Gemcitabine: metabolism, mechanisms of action, and self-potentiation.
Plunkett, W. K., Huang, P., Xu, Y.-Z., Heinemann, V., Grunewald, R., & Gandhi, V. V. (1995) · PubMed · Cited by 753
Molecular Evolution of Human Coronavirus Genomes
Forni, D., Cagliani, R., Clerici, M., & Sironi, M. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2016.09.001 · Cited by 739
de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 736
Millet, J. K., & Whittaker, G. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407087111 · Cited by 698
From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
Hilgenfeld, R. (2014) · The FEBS Journal · doi:10.1111/febs.12936 · Cited by 660
Dyall, J., Coleman, C. M., Hart, B. J., Venkataraman, T., Holbrook, M. R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Jahrling, P. B., Laidlaw, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03036-14 · Cited by 660
Chan, J. F.-W., Yao, Y., Yeung, M.-L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yu, P., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv392 · Cited by 608
Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis
Blanchard, E., Belouzard, S., Goueslain, L., Wakita, T., Dubuisson, J., Wychowski, C., & Rouillé, Y. (2006) · Journal of Virology · doi:10.1128/jvi.00024-06 · Cited by 599
Protease inhibitors targeting coronavirus and filovirus entry
Zhou, Y., Vedantham, P., Lu, K., Agudelo, J., Carrion, R., Nunneley, J. W., Barnard, D., Pöhlmann, S., McKerrow, J. H., Renslo, A. R., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.01.011 · Cited by 583
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease.
McIntosh, K., Dees, J. H., Becker, W. B., Kapikian, A. Z., & Chanock, R. M. (1967) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.57.4.933 · Cited by 581
Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Rossignol, J.-F. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.07.014 · Cited by 556
Wu, M., Hemesath, T. J., Takemoto, C. M., Horstmann, M. A., Wells, A. G., Price, E. R., Fisher, D. Z., & Fisher, D. E. (2000) · Genes & Development · doi:10.1101/gad.14.3.301 · Cited by 527
Neuroinvasion by Human Respiratory Coronaviruses
Arbour, N., Day, R., Newcombe, J., & Talbot, P. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.8913-8921.2000 · Cited by 522
Small molecules targeting severe acute respiratory syndrome human coronavirus
Wu, C.-Y., Jan, J.-T., Ma, S.-H., Kuo, C.-J., Juan, H.-F., Cheng, Y.-S. E., Hsu, H.-H., Huang, H.-C., Wu, D., Brik, A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403596101 · Cited by 521
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
Lo, M. K., Jordan, R., Arvey, A., Sudhamsu, J., Shrivastava-Ranjan, P., Hotard, A. L., Flint, M., McMullan, L. K., Siegel, D., Clarke, M. O., et al. (2017) · Scientific Reports · doi:10.1038/srep43395 · Cited by 513
A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication
Ratia, K., Pegan, S., Takayama, J., Sleeman, K., Coughlin, M., Baliji, S., Chaudhuri, R., Fu, W., Prabhakar, B. S., Johnson, M. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805240105 · Cited by 507
Omrani, A. S., Saad, M. M., Baig, K., Bahloul, A., Abdul-Matin, M., Alaidaroos, A. Y., Almakhlafi, G. A., Albarrak, M. M., Memish, Z. A., & Albarrak, A. M. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70920-x · Cited by 493
Treatment of SARS with human interferons
Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., & Doerr, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13973-6 · Cited by 467
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV–infected rhesus macaques
Falzarano, D., de Wit, E., Rasmussen, A. L., Feldmann, F., Okumura, A., Scott, D. P., Brining, D., Bushmaker, T., Martellaro, C., Baseler, L., et al. (2013) · Nature Medicine · doi:10.1038/nm.3362 · Cited by 445
Coronavirus HKU1 and Other Coronavirus Infections in Hong Kong
Lau, S. K. P., Woo, P. C. Y., Yip, C. C. Y., Tse, H., Tsoi, H.-W., Cheng, V. C. C., Lee, P., Tang, B. S. F., Cheung, C. H. Y., Lee, R. A., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.02614-05 · Cited by 442
Geller, C., Varbanov, M., & Duval, R. E. (2012) · Viruses · doi:10.3390/v4113044 · Cited by 434
Chan, K., Lai, S. T., Chu, C., Tsui, E. L. H., Tam, C. Y., Wong, M. M.-L., Tse, M. W., Que, T. L., Peiris, M. J. S., Sung, J. J. �., et al. (2003) · PubMed · Cited by 423
Kindrachuk, J., Ork, B., Hart, B. J., Mazur, S., Holbrook, M. R., Frieman, M. B., Traynor, D., Johnson, R. F., Dyall, J., Kuhn, J. H., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03659-14 · Cited by 407
Lau, S. K. P., Lau, C. C. Y., Chan, K.-H., Li, C. P. Y., Chen, H., Jin, D.-Y., Chan, J. F. W., Woo, P. C. Y., & Yuen, K.-Y. (2013) · Journal of General Virology · doi:10.1099/vir.0.055533-0 · Cited by 392
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Chan, J. F. W., Chan, K.-H., Kao, R. Y. T., To, K. K. W., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.029 · Cited by 385
Interferon Alfacon-1 Plus Corticosteroids in Severe Acute Respiratory Syndrome: A Preliminary Study
Loutfy, M. R., Blatt, L. M., Siminovitch, K. A., Ward, S., Wolff, B., Lho, H., Pham, D. H., Deif, H., LaMere, E. A., Chang, M., et al. (2003) · JAMA · doi:10.1001/jama.290.24.3222 · Cited by 381
Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques
Haagmans, B. L., Kuiken, T., Martina, B. E., Fouchier, R. A. M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D., de Jong, T., Itamura, S., Chan, K.-H., et al. (2004) · Nature Medicine · doi:10.1038/nm1001 · Cited by 381
Inoue, Y., Tanaka, N., Tanaka, Y., Inoue, S., Morita, K., Zhuang, M., Hattori, T., & Sugamura, K. (2007) · Journal of Virology · doi:10.1128/jvi.00253-07 · Cited by 369
Wu, K., Li, W., Peng, G., & Li, F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908837106 · Cited by 355
A MURINE VIRUS (JHM) CAUSING DISSEMINATED ENCEPHALOMYELITIS WITH EXTENSIVE DESTRUCTION OF MYELIN
Cheever, F. S., Daniels, J. B., Pappenheimer, A. M., & Bailey, O. T. (1949) · Journal of Experimental Medicine · doi:10.1084/jem.90.3.181 · Cited by 354
Bertram, S., Dijkman, R., Habjan, M., Heurich, A., Gierer, S., Glowacka, I., Welsch, K., Winkler, M., Schneider, H., Hofmann-Winkler, H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.03372-12 · Cited by 350
de Wilde, A. H., Raj, V. S., Oudshoorn, D., Bestebroer, T. M., van Nieuwkoop, S., Limpens, R. W. A. L., Posthuma, C. C., van der Meer, Y., Bárcena, M., Haagmans, B. L., et al. (2013) · Journal of General Virology · doi:10.1099/vir.0.052910-0 · Cited by 348
Bertram, S., Glowacka, I., Müller, M. A., Lavender, H., Gnirss, K., Nehlmeier, I., Niemeyer, D., He, Y., Simmons, G., Drosten, C., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05300-11 · Cited by 329
Cotten, M., Watson, S. J., Kellam, P., Al-Rabeeah, A. A., Makhdoom, H. Q., Assiri, A., Al-Tawfiq, J. A., Alhakeem, R. F., Madani, H., AlRabiah, F. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61887-5 · Cited by 323
Al-Tawfiq, J. A., Momattin, H., Dib, J., & Memish, Z. A. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.12.003 · Cited by 322
High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses.
Shen, L., Niu, J., Wang, C., Huang, B., Wang, W., Zhu, N., Deng, Y., Wang, H., Ye, F., Cen, S., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00023-19 · Cited by 319
Bosch, B. J., Bartelink, W., & Rottier, P. J. M. (2008) · Journal of Virology · doi:10.1128/jvi.00415-08 · Cited by 315
Menachery, V. D., Eisfeld, A. J., Schäfer, A., Josset, L., Sims, A. C., Proll, S., Fan, S., Li, C., Neumann, G., Tilton, S. C., et al. (2014) · mBio · doi:10.1128/mbio.01174-14 · Cited by 305
O'Keefe, B. R., Giomarelli, B., Barnard, D. L., Shenoy, S. R., Chan, P. K. S., McMahon, J. B., Palmer, K. E., Barnett, B. W., Meyerholz, D. K., Wohlford-Lenane, C. L., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02322-09 · Cited by 303
Coronavirus 229E-Related Pneumonia in Immunocompromised Patients
Pene, F., Merlat, A., Vabret, A., Rozenberg, F., Buzyn, A., Dreyfus, F., Cariou, A., Freymuth, F., & Lebon, P. (2003) · Clinical Infectious Diseases · doi:10.1086/377612 · Cited by 303
Josset, L., Menachery, V. D., Gralinski, L. E., Agnihothram, S., Sova, P., Carter, V. S., Yount, B. L., Graham, R. L., Baric, R. S., & Katze, M. G. (2013) · mBio · doi:10.1128/mbio.00165-13 · Cited by 293
Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge
Lo, M. K., Feldmann, F., Gary, J. M., Jordan, R., Bannister, R. M., Cronin, J., Patel, N. R., Klena, J. D., Nichol, S. T., Cihlář, T., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau9242 · Cited by 293
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
Falzarano, D., de Wit, E., Martellaro, C., Callison, J., Munster, V. J., & Feldmann, H. (2013) · Scientific Reports · doi:10.1038/srep01686 · Cited by 273
Pohjala, L., Utt, A., Varjak, M., Lulla, A., Merits, A., Ahola, T., & Tammela, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028923 · Cited by 270
Huang, X., Dong, W., Milewska, A., Golda, A., Qi, Y., Zhu, Q. K., Marasco, W. A., Baric, R. S., Sims, A. C., Pyrc, K., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00854-15 · Cited by 261
Báez-Santos, Y. M., Barraza, S. J., Wilson, M. W., Agius, M. P., Mielech, A. M., Davis, N. M., Baker, S. C., Larsen, S. D., & Mesecar, A. D. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401712t · Cited by 255
A broad-spectrum antiviral targeting entry of enveloped viruses
Wolf, M. C., Freiberg, A. N., Zhang, T., Akyol-Ataman, Z., Grock, A., Hong, P. W., Li, J., Watson, N. F., Fang, A. Q., Aguilar, H. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909587107 · Cited by 254
Structure and Inhibition of the SARS Coronavirus Envelope Protein Ion Channel
Pervushin, K., Tan, E., Parthasarathy, K., Lin, X., Jiang, F. L., Yu, D., Vararattanavech, A., Soong, T. W., Liu, D. X., & Torres, J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000511 · Cited by 253
Haffizulla, J., Hartman, A., Hoppers, M., Resnick, H., Samudrala, S., Ginocchio, C., Bardin, M., & Rossignol, J.-F. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70717-0 · Cited by 251
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
Lin, M.-H., Moses, D. C., Hsieh, C.-H., Cheng, S.-C., Chen, Y.-H., Sun, C.-Y., & Chou, C.-Y. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.015 · Cited by 250
An Outbreak of Coronavirus OC43 Respiratory Infection in Normandy, France
Vabret, A., Mourez, T., Gouarin, S., Petitjean, J., & Freymuth, F. (2003) · Clinical Infectious Diseases · doi:10.1086/374222 · Cited by 248
A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents
Madrid, P. B., Chopra, S., Manger, I. D., Gilfillan, L., Keepers, T. R., Shurtleff, A. C., Green, C. E., Iyer, L. V., Dilks, H. H., Davey, R. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060579 · Cited by 247
Kim, Y., Liu, H., Galasiti Kankanamalage, A. C., Weerasekara, S., Hua, D. H., Groutas, W. C., Chang, K.-O., & Pedersen, N. C. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005531 · Cited by 238
MERS-CoV papain-like protease has deISGylating and deubiquitinating activities
Mielech, A. M., Kilianski, A., Baez-Santos, Y. M., Mesecar, A. D., & Baker, S. C. (2014) · Virology · doi:10.1016/j.virol.2013.11.040 · Cited by 231
A MURINE VIRUS (JHM) CAUSING DISSEMINATED ENCEPHALOMYELITIS WITH EXTENSIVE DESTRUCTION OF MYELIN
Bailey, O. T., Pappenheimer, A. M., Cheever, F. S., & Daniels, J. B. (1949) · Journal of Experimental Medicine · doi:10.1084/jem.90.3.195 · Cited by 228
van Doremalen, N., Miazgowicz, K. L., Milne-Price, S., Bushmaker, T., Robertson, S., Scott, D., Kinne, J., McLellan, J. S., Zhu, J., & Munster, V. J. (2014) · Journal of Virology · doi:10.1128/jvi.00676-14 · Cited by 225
Hart, B. J., Dyall, J., Postnikova, E., Zhou, H., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Frieman, M. B., Holbrook, M. R., Jahrling, P. B., et al. (2014) · Journal of General Virology · doi:10.1099/vir.0.061911-0 · Cited by 211
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome
Hui, D. S., Memish, Z. A., & Zumla, A. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000046 · Cited by 209
Müller, C., Schulte, F. W., Lange-Grünweller, K., Obermann, W., Madhugiri, R., Pleschka, S., Ziebuhr, J., Hartmann, R. K., & Grünweller, A. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.010 · Cited by 200
Detection of the New Human Coronavirus HKU1: A Report of 6 Cases
Vabret, A., Dina, J., Gouarin, S., Petitjean, J., Corbet, S., & Freymuth, F. (2006) · Clinical Infectious Diseases · doi:10.1086/500136 · Cited by 198
Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice
Jacomy, H., Fragoso, G., Almazan, G., Mushynski, W. E., & Talbot, P. J. (2006) · Virology · doi:10.1016/j.virol.2006.01.049 · Cited by 196
Entry of Human Coronavirus NL63 into the Cell
Milewska, A., Nowak, P., Owczarek, K., Szczepanski, A., Zarebski, M., Hoang, A., Berniak, K., Wojarski, J., Zeglen, S., Baster, Z., et al. (2018) · Journal of Virology · doi:10.1128/jvi.01933-17 · Cited by 195
Shalhoub, S., Farahat, F., Al-Jiffri, A., Simhairi, R., Shamma, O., Siddiqi, N., & Mushtaq, A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv085 · Cited by 189
Structure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 Inhibitor
Huentelman, M. J., Zubcevic, J., Hernández Prada, J. A., Xiao, X., Dimitrov, D. S., Raizada, M. K., & Ostrov, D. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000146120.29648.36 · Cited by 188
Cheng, K.-W., Cheng, S.-C., Chen, W.-Y., Lin, M.-H., Chuang, S.-J., Cheng, I.-H., Sun, C.-Y., & Chou, C.-Y. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2014.12.011 · Cited by 186
Li, W., Sui, J., Huang, I.-C., Kuhn, J. H., Radoshitzky, S. R., Marasco, W. A., Choe, H., & Farzan, M. (2007) · Virology · doi:10.1016/j.virol.2007.04.035 · Cited by 185
Adedeji, A. O., Severson, W., Jonsson, C., Singh, K., Weiss, S. R., & Sarafianos, S. G. (2013) · Journal of Virology · doi:10.1128/jvi.00998-13 · Cited by 183
Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations
Walsh, E. E., Shin, J. H., & Falsey, A. R. (2013) · Journal of Infectious Diseases · doi:10.1093/infdis/jit393 · Cited by 182
Mielech, A. M., Chen, Y., Mesecar, A. D., & Baker, S. C. (2014) · Virus Research · doi:10.1016/j.virusres.2014.01.025 · Cited by 179
Clinical management and infection control of SARS: Lessons learned
Cheng, V. C., Chan, J. F., To, K. K., & Yuen, K. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.016 · Cited by 176
Griffith, J. F., Antonio, G. E., Kumta, S. M., Hui, D. S. C., Wong, J. K. T., Joynt, G. M., Wu, A. K. L., Cheung, A. Y. K., Chiu, K. H., Chan, K. M., et al. (2005) · Radiology · doi:10.1148/radiol.2351040100 · Cited by 176
Fatal Aspergillosis in a Patient with SARS Who Was Treated with Corticosteroids
Wang, H., Ding, Y., Li, X., Yang, L., Zhang, W., & Kang, W. (2003) · New England Journal of Medicine · doi:10.1056/nejm200307313490519 · Cited by 166
Tomar, S., Johnston, M. L., St. John, S. E., Osswald, H. L., Nyalapatla, P. R., Paul, L. N., Ghosh, A. K., Denison, M. R., & Mesecar, A. D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.651463 · Cited by 164
Suppression of Coronavirus Replication by Cyclophilin Inhibitors
Tanaka, Y., Sato, Y., & Sasaki, T. (2013) · Viruses · doi:10.3390/v5051250 · Cited by 158
Ghosh, A. K., Takayama, J., Rao, K. V., Ratia, K. M., Chaudhuri, R., Mulhearn, D. C., Lee, H., Nichols, D. B., Baliji, S., Baker, S. C., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1004489 · Cited by 151
Ghosh, A. K., Xi, K., Ratia, K. M., Santarsiero, B. D., Fu, W., Harcourt, B. H., Rota, P. A., Baker, S. C., Johnson, M. E., & Mesecar, A. D. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050548m · Cited by 142
Lin, S.-Y., Liu, C., Chang, Y., Zhao, J., Perlman, S. M., & Hou, M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500089r · Cited by 137
Ghosh, A. K., Gong, G., Grum-Tokars, V. L., Mulhearn, D. C., Baker, S. C., Coughlin, M. M., Prabhakar, B. S., Sleeman, K., Johnson, M. E., & Mesecar, A. D. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.082 · Cited by 137
Adedeji, A. O., Singh, K., Calcaterra, N. E., DeDiego, M. L., Enjuanes, L., Weiss, S. R., & Sarafianos, S. G. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00957-12 · Cited by 137
Early events during human coronavirus OC43 entry to the cell
Owczarek, K., Szczepański, A., Milewska, A., Baster, Z., Rajfur, Z., Sarna, M., & Pyrć, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-25640-0 · Cited by 137
Persistent Infection of Human Oligodendrocytic and Neuroglial Cell Lines by Human Coronavirus 229E
Arbour, N., Ékandé, S., Côté, G., Lachance, C., Chagnon, F., Tardieu, M., Cashman, N. R., & Talbot, P. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3326-3337.1999 · Cited by 133
Middle East respiratory syndrome (MERS): A new zoonotic viral pneumonia
Cunha, C. B., & Opal, S. M. (2014) · Virulence · doi:10.4161/viru.32077 · Cited by 128
Recently Discovered Human Coronaviruses
Wevers, B. A., & van der Hoek, L. (2009) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2009.07.007 · Cited by 127
Turlington, M., Chun, A. C., Tomar, S., Eggler, A. L., Grum-Tokars, V. L., Jacobs, J., Daniels, J. S., Dawson, E. S., Saldanha, A., Chase, P. S., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.112 · Cited by 125
Ghosh, A., Takayama, J., Aubin, Y., Ratia, K., Chaudhuri, R., Baez, Y., Sleeman, K., Coughlin, M., Nichols, D., Mulhearn, D. C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900611t · Cited by 124
Spanakis, N., Tsiodras, S., Haagmans, B. L., Raj, V. S., Pontikis, K., Koutsoukou, A., Koulouris, N. G., Osterhaus, A. D. M. E., Koopmans, M., & Tsakris, A. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.026 · Cited by 123
ATP1A1-Mediated Src Signaling Inhibits Coronavirus Entry into Host Cells
Tait‐Burkard, C., Verheije, M. H., Haagmans, B. L., van Kuppeveld, F. J. M., Rottier, P. J. M., Bosch, B., & de Haan, C. A. M. (2015) · Journal of Virology · doi:10.1128/jvi.03274-14 · Cited by 123
Inhibitor Recognition Specificity of MERS-CoV Papain-like Protease May Differ from That of SARS-CoV
Lee, H., Lei, H., Santarsiero, B. D., Gatuz, J. L., Cao, S., Rice, A. J., Patel, K., Szypulinski, M. Z., Ojeda, I., Ghosh, A. K., et al. (2015) · ACS Chemical Biology · doi:10.1021/cb500917m · Cited by 123
Gorse, G. J., O’Connor, T., Hall, S. L., Vitale, J. N., & Nichol, K. L. (2009) · The Journal of Infectious Diseases · doi:10.1086/597122 · Cited by 122
Paranjpe, A., Zhang, R., Ali‐Osman, F., Bobustuc, G. C., & Srivenugopal, K. S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt366 · Cited by 121
Adedeji, A. O., Singh, K., Kassim, A., Coleman, C. M., Elliott, R., Weiss, S. R., Frieman, M. B., & Sarafianos, S. G. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02994-14 · Cited by 120
Barton, C. R., Kouokam, J. C., Lasnik, A. B., Foreman, O., Cambon, A. C., Brock, G. N., Montefiori, D. C., Vojdani, F., McCormick, A. A., O’Keefe, B. R., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01407-13 · Cited by 120
A Mechanistic Paradigm for Broad-Spectrum Antivirals that Target Virus-Cell Fusion
Vigant, F., Lee, J., Hollmann, A., Tanner, L. B., Ataman, Z. A., Yun, T., Shui, G., Aguilar, H. C., Zhang, D., Meriwether, D., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003297 · Cited by 117
Regnard, C., Twycross, R., Mihalyo, M., & Wilcock, A. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.06.001 · Cited by 117
Kankanamalage, A. C. G., Kim, Y., Damalanka, V. C., Rathnayake, A. D., Fehr, A. R., Mehzabeen, N., Battaile, K. P., Lovell, S., Lushington, G. H., Perlman, S. M., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.004 · Cited by 114
Shie, J., Fang, J., Kuo, T., Kuo, C., Liang, P., Huang, H., Wu, Y.-T., Jan, J., Cheng, Y. E., & Wong, C. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.065 · Cited by 111
In Vitro and In Vivo Studies of the Trypanocidal Properties of WRR-483 against Trypanosoma cruzi
Chen, Y., Brinen, L. S., Kerr, I. D., Hansell, E. J., Doyle, P. S., McKerrow, J. H., & Roush, W. R. (2010) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000825 · Cited by 107
Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors
Kumar, V., Tan, K.-P., Wang, Y., Lin, S., & Liang, P. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.013 · Cited by 105
Channappanavar, R., Lu, L., Xia, S., Du, L., Meyerholz, D. K., Perlman, S. M., & Jiang, S. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv325 · Cited by 103
Ghosh, A. K., Xi, K., Grum-Tokars, V. L., Xu, X., Ratia, K. M., Fu, W., Houser, K. V., Baker, S. C., Johnson, M. E., & Mesecar, A. D. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.08.031 · Cited by 102
The management of coronavirus infections with particular reference to SARS
Wong, S. S. Y., & Yuen, K. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn243 · Cited by 101
Medical treatment of viral pneumonia including SARS in immunocompetent adult
Cheng, V. C., Tang, B. S. F., Wu, A. H. B., Chu, C., & Yuen, K. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.07.010 · Cited by 101
Deng, X., John, S. E. S., Osswald, H. L., O’Brien, A., Banach, B. S., Sleeman, K., Ghosh, A. K., Mesecar, A. D., & Baker, S. C. (2014) · Journal of Virology · doi:10.1128/jvi.01528-14 · Cited by 100
Structure-Based Design, Synthesis, and Evaluation of Peptide-Mimetic SARS 3CL Protease Inhibitors
Akaji, K., Konno, H., Mitsui, H., Teruya, K., Shimamoto, Y., Hattori, Y., Ozaki, T., Kusunoki, M., & Sanjoh, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200870n · Cited by 100
Kumar, V., Shin, J. S., Shie, J., Ku, K. B., Kim, C., Go, Y. Y., Huang, K.-F., Kim, M., & Liang, P. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.02.007 · Cited by 100
Recent Developments in Anti-Severe Acute Respiratory Syndrome Coronavirus Chemotherapy
Barnard, D. L., & Kumaki, Y. (2011) · Future Virology · doi:10.2217/fvl.11.33 · Cited by 98
Characterization and Inhibition of SARS-Coronavirus Main Protease
Liang, P. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606776287090 · Cited by 98
Hesperidin, A Popular Antioxidant Inhibits Melanogenesis via Erk1/2 Mediated MITF Degradation
Lee, H., Lee, W. K., Chang, S. E., & Lee, G.-Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818384 · Cited by 95
Ohnuma, K., Haagmans, B. L., Hatano, R., Raj, V. S., Mou, H., Iwata, S., Dang, N. H., Bosch, B., & Morimoto, C. (2013) · Journal of Virology · doi:10.1128/jvi.02448-13 · Cited by 95
Porotto, M., Orefice, G., Yokoyama, C. C., Mungall, B. A., Realubit, R. B., Sganga, M. L., Aljofan, M., Whitt, M. A., Glickman, J. F., & Moscona, A. (2009) · Journal of Virology · doi:10.1128/jvi.00164-09 · Cited by 93
Karypidou, K., Ribone, S. R., Quevedo, M. A., Persoons, L., Pannecouque, C. C., Helsen, C., Claessens, F., & Dehaen, W. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.09.019 · Cited by 91
Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro
Shin, J. S., Jung, E., Kim, M., Baric, R. S., & Go, Y. Y. (2018) · Viruses · doi:10.3390/v10060283 · Cited by 86
Khalid, M., Rabiah, F. A., Khan, B., Mobeireek, A. F., Butt, T. S., & Mutairy, E. A. (2014) · Antiviral Therapy · doi:10.3851/imp2792 · Cited by 83
de Wilde, A. H., Falzarano, D., Zevenhoven-Dobbe, J. C., Beugeling, C., Fett, C., Martellaro, C., Posthuma, C. C., Feldmann, H., Perlman, S. M., & Snijder, E. J. (2016) · Virus Research · doi:10.1016/j.virusres.2016.11.011 · Cited by 82
Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
Shimamoto, Y., Hattori, Y., Kobayashi, K., Teruya, K., Sanjoh, A., Nakagawa, A., Yamashita, E., & Akaji, K. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.028 · Cited by 81
Butler, N. S., Pewe, L. L., Trandem, K., & Perlman, S. M. (2006) · Virology · doi:10.1016/j.virol.2005.11.044 · Cited by 79
Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers
Park, S. Y., Lee, J. S., Son, J. S., Ko, J. H., Peck, K. R., Jung, Y., Woo, H., Joo, Y., Eom, J. S., & Shi, H. (2018) · Journal of Hospital Infection · doi:10.1016/j.jhin.2018.09.005 · Cited by 78
Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses
Kang, H., Kim, C., Kim, D., Song, J.-H., Choi, M., Choi, K., Kang, M.-G., Lee, K., Kim, H. S., Shin, J. S., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.10.011 · Cited by 74
Giner‐Sorolla, A., & Bendich, A. (1958) · Journal of the American Chemical Society · doi:10.1021/ja01554a041 · Cited by 71
Kilianski, A., & Baker, S. C. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.11.004 · Cited by 68
Structural Basis for Inactivation of Giardia lamblia Carbamate Kinase by Disulfiram
Galkin, A. G., Kulakova, L., Lim, K., Chen, C. Z., Zheng, W., Turko, I. V., & Herzberg, O. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.553123 · Cited by 62
Pu, Y., & Zhang, X. (2008) · Journal of Virology · doi:10.1128/jvi.00837-08 · Cited by 54
Hollmann, A., Castanho, M. A. R. B., Lee, B., & Santos, N. C. (2014) · Biochemical Journal · doi:10.1042/bj20131058 · Cited by 50
Liu, Q., Xia, S., Sun, Z., Wang, Q., Du, L., Lu, L., & Jiang, S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03977-14 · Cited by 45
Smuts, H. E. M. (2008) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2008.00049.x · Cited by 31
Cure of Hookworm Infection with a Cysteine Protease Inhibitor
Vermeire, J. J., Lantz, L. D., & Caffrey, C. R. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001680 · Cited by 31
Cited by
Coronavirus Disease 2019–COVID-19
Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla-Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00028-20 · Cited by 1,876
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
Bojkova, D., Klann, K., Koch, B., Widera, M., Krause, D., Ciesek, S., Cinatl, J., & Münch, C. (2020) · Nature · doi:10.1038/s41586-020-2332-7 · Cited by 1,010
Dhama, K., Sharun, K., Tiwari, R., Dadar, M., Malik, Y. S., Singh, K. P., & Chaicumpa, W. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1735227 · Cited by 623
Malik, Y. S., Sircar, S., Bhat, S., Sharun, K., Dhama, K., Dadar, M., Tiwari, R., & Chaicumpa, W. (2020) · Veterinary Quarterly · doi:10.1080/01652176.2020.1727993 · Cited by 498
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
Nile, S. H., Nile, A., Qiu, J., Li, L., Jia, X., & Kai, G. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.002 · Cited by 440
Metadata
- Authors
- Pillaiyar, T., Meenakshisundaram, S., & Manickam, M.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 25
- Issue
- 4
- Pages
- 668-688
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W3003448227
- Cited by
- 361
- References
- 144
- FWCI
- 9.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.